On 23 Jan 2020, Zealand Pharma A/S (NASDAQ: ZEAL) spotted trading -1.41% off 52-week high price. On the other end, the stock has been noted 160.57% away from the low price over the last 52-weeks. The stock changed -1.41% to recent value of $36.48. The stock transacted 1900 shares during most recent day however it has an average volume of 11.39K shares. The company has 35.99M of outstanding shares and 26.78M shares were floated in the market.
Zealand Pharma A/S (ZEAL) recently reported financial results through the third quarter of 2019.
Financial results for the first nine months of 2019
Revenue DKK 29.8M / USD 4.4M (DKK 24.9M / USD 3.9M in the first nine months of 2018).
Net operating expenses DKK 431.5M / USD 62.9M (DKK 330.6M / USD 51.3M in the first nine months of 2018).
Net operating result DKK –402.1M / USD –58.7M (DKK 797.5M / USD 123.8M in the first nine months of 2018).
Cash including marketable securities amounted to DKK 1,543.2M / USD 225.0M as of September 30, 2019 (September 30, 2018: DKK 1,478.6M / USD 229.6M).
Financial guidance for 2019
In 2019, Zealand expects revenue from existing license contracts. However, since such revenue is uncertain in terms of amount and timing, Zealand does not guide on such revenue.
Net operating expenses in 2019 are predictable to be within DKK 580-600M, which is in line with the financial guidance provided in financial report for 2019 H1 (Q2).
The price moved ahead of 6.05% from the mean of 20 days, 11.24% from mean of 50 days SMA and performed 45.71% from mean of 200 days price. Company’s performance for the week was 1.11%, 11.42% for month and YTD performance remained 9.88%.